The Latest Cardiac and Vascular News
SAN ANTONIO, Oct. 26, 2017 /PRNewswire/ — CeloNova BioSciences, a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced that the U.S. Federal Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary COBRA PzF™ NanoCoated Coronary […]
A new study has found females and minorities have a greater risk of restenosis and subsequent MACE than “white” men after receiving everolimus-eluting stent implantation. The Study Setup A cohort study that pulled thousands of patients from both the PLATINUM Diversity and PROMUS Element Plus Post-Approval looked at groups of men, women […]
SAN FRANCISCO–(BUSINESS WIRE)–Bay Labs, a medical technology company at the forefront of applying artificial intelligence to cardiovascular imaging, today announced that Emeritus Professor of Medicine (Cardiology) at Emory University School of Medicine and the company’s Chief Medical Officer Randolph P. Martin, M.D. FACC, FASE, has been invited to be a […]
WASHINGTON, Oct. 25, 2017 /PRNewswire/ – Baylis Medical Company, a leading developer, manufacturer, and supplier of state-of-the-art interventional cardiology products, has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association’s (AdvaMed) Accel Board of Directors. “I am honoured to be appointed to the AdvaMed Accel Board and look forward to […]
KFAR SABA, Israel, Oct. 24, 2017 /PRNewswire/ — Cathworks, a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today that the first patient has been enrolled in the FAST-FFR (FFRangio Accuracy vs. STandard FFR) clinical trial. This global pivotal trial is designed to assess the efficacy […]
MARLBOROUGH, Mass., Oct. 23, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced key data that will be presented at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Denver, on October 29 – November 2. WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device data will be featured in a […]
BROOKLYN PARK, Minn., Oct. 24, 2017 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, today announced that its medical device for mitral regurgitation (MR) will be highlighted in the Shark Tank Innovation Competition at the Transcatheter Cardiovascular Therapeutics (TCT) meeting held October 29-November 2, […]
NEWTOWN, Pa., Oct. 23, 2017 /PRNewswire/ — Micro Interventional Devices, Inc. announced today the second successful implantation of its MIA (Minimally Invasive Annuloplasty) technology. The patient was enrolled in the first arm of the STTAR (Study of Transcatheter Tricuspid Annular Repair) clinical trial studying the safety and efficacy of MID’s MIA device […]
DUBLIN – October 23, 2017 – Medtronic (NYSE:MDT) today announced the first patient implant in the APOLLO Trial – the pivotal trial designed to evaluate the Intrepid(TM) TMVR system following receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA). As the first-ever pivotal trial for transcatheter […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will incorporate the HeartFlow® FFRct Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the CorPath® GRX System to evaluate the feasibility and utility of clinical decision support. “We are […]
